Latest Regulatory Approvals News

Atlantic Lithium has reported a year of major progress at its Ewoyaa lithium project, including Ghanaian parliamentary approval of its mining lease and a proposed US$210 million takeover by Zhejiang Huayou Cobalt. But the audited accounts also flag material uncertainty over funding if the scheme does not proceed.

Venari Minerals says it knows of no undisclosed information behind a sharp rise in its share price and trading volume. The company points instead to ongoing Red Mountain drilling and a proposed exploration program still awaiting US regulatory approval.

Emyria has secured a limited in-person speaking position at a US FDA hearing examining how psychedelic medicines could be delivered safely and at scale. The appearance gives the ASX-listed company a regulatory platform, but does not represent FDA approval, funding or a commercial agreement.

Eagers Automotive has signed a non-binding agreement to acquire a 50% interest in Zagame Automotive Group, gaining exposure to 14 premium and luxury vehicle brands across Melbourne and Adelaide. The company expects the proposed joint venture to be immediately earnings accretive, although completion remains conditional and no transaction value has been disclosed.

Optiscan Imaging has reached an 84-case milestone in its live digital pathology study with Australian Clinical Labs, testing the InForm platform across a broad range of tissue types and disease settings. The data may support future regulatory submissions and commercial discussions, but the announcement does not disclose diagnostic accuracy metrics or regulatory approval.

St Barbara will sell its remaining New Simberi interest and Tabar Islands exploration exposure to Lingbao for A$453 million in cash, while retaining royalties over future production. The deal could leave the gold developer with about A$880 million in cash, but completion still depends on regulatory and potentially shareholder approvals.

Exultant Mining has reported its first consolidated annual results since listing, recording a $1.526 million loss and holding $3.50 million in cash at 30 June 2026. Exploration has advanced across Black Hammer and Peak View, but the company remains dependent on future funding and assay results to justify its portfolio.

OncoSil Medical has moved closer to local production after contract manufacturer Cyclotek secured ISO 13485 certification for its quality management system. Production at the Macquarie Park facility remains targeted for the end of 2Q FY27, subject to further regulatory approval.

Nelson Resources has lodged a Notice of Intent to collect up to 1,000 short tons of remnant mineralised material from the Orleans Mine in Nevada for bulk-scale metallurgical testing. The program could test whether laboratory recovery results translate to commercial-mill conditions, but remains subject to approval, bonding and the appointment of a third-party mill.

Sunrise Energy Metals has put its Syerston scandium project on a stronger financial footing, ending FY2026 with A$115.4 million in cash and a conditional US$400 million debt commitment. The project still faces a decisive sequence of tests: final investment approval, binding offtake agreements, financing conditions and construction execution.

Emperor Energy has signed a term sheet to secure the Valaris 107 jack-up rig for its Judith-2 appraisal well, targeted for April 2027. The deal commits US$3.5 million before the full drilling contract is finalised, while environmental approval remains outstanding.

Barton Gold has secured approval for the environmental scope governing development studies at its Tunkillia gold and silver project in South Australia. The milestone moves the project towards a Mining Lease application, with updated resources, Ore Reserves and a pre-feasibility study targeted for the first quarter of 2027.